Search clinical trials for: unresectable hepatocellular carcinoma

Total 31129 results

Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

Comparing 3 Schedules of Alimta Plus Gemzar

Neoplasms | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Eli Lilly and Company

Completed

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Breast Neoplasms

United States
Eli Lilly and Company

Completed

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

Breast Neoplasms

United States, Argentina, Chile, India, Mexico
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Johannes Gutenberg University Mainz

Completed

Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia

Cancer | Ulcerative Colitis | Intraepithelial Neoplasia

Germany
Celgene Corporation

Completed

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States
Chiron Corporation

Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Adenocarcinoma | Stomach Neoplasms | Esophageal Neoplasms

United States
LanZhou University

Completed

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Bladder Neoplasms
AZ-VUB
Hoffmann-La Roche

Unknown

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Lung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-Alveolar

Belgium
Novacea

Unknown

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Non Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)

Canada, United States
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
University Hospital Muenster
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Multicenter Study Differentiated Thyroid Carcinoma

Thyroid Neoplasms

Austria, Germany, Switzerland
University of California, Irvine
National Cancer Institute (NCI)

Completed

Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit

Cervical Intraepithelial Neoplasia

United States
Charite University, Berlin, Germany
ribosepharm GmbH

Unknown

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Recurrent Small Cell Lung Cancer

Germany
Celgene Corporation
Prologue Research International

Terminated

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
North Eastern German Society of Gynaecological...

Completed

Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

Ovarian Cancer

Germany
Austrian Breast & Colorectal Cancer Study Group

Terminated

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Rectal Cancer Dukes B, Dukes C

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
National Taiwan University Hospital

Unknown

The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Laryngeal Cancer | Hypopharyngeal Cancer | Metastasis

Taiwan
National Taiwan University Hospital

Unknown

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Laryngeal Cancer | Hypopharyngeal Cancer | Oral Cancer

Taiwan
National Taiwan University Hospital

Unknown

Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients

Nasopharyngeal Cancer

Taiwan
National Taiwan University Hospital

Unknown

The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Laryngeal Cancer | Hypopharyngeal Cancer

Taiwan
National Taiwan University Hospital

Unknown

The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary

Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma

Taiwan
European Institute of Oncology

Completed

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Carcinoma | Breast Neoplasms
Tel-Aviv Sourasky Medical Center
Radiation Therapy Oncology Group

Unknown

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis

Israel
OSI Pharmaceuticals

Completed

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Gastric Adenocarcinoma | Gastroesophageal Adenocarcinoma

United States, United Kingdom, Belgium
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma

Trophoblastic Neoplasms | Choriocarcinoma

Taiwan
Tampere University
Finnish Prostate Cancer Group

Unknown

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Patients With T1-4 Advanced Prostate Cancer

Finland
Centre Leon Berard
French Immunotherapy Intergroup; SCAPP (Sub-Cutaneous Administration Proleukin...

Completed

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Metastatic Renal Cell Carcinoma

France
Taipei Veterans General Hospital, Taiwan

Completed

N-Butyl-2-Cyanoacrylate Injection Versus Band Ligation for Gastric Variceal Hemorrhage

Gastric Variceal Hemorrhage

Taiwan
Charite University, Berlin, Germany
Pfizer; Aventis Pharmaceuticals

Unknown

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Small Cell Lung Cancer

Germany
Charite University, Berlin, Germany

Unknown

WT1 Peptid Vaccination in Carcinomas

WT1 Expressing Carcinoma

Germany
MANTA 1 Study Italian Collaborative Group
Bristol-Myers Squibb

Unknown

Maintenance Chemotherapy in Metastatic Breast Cancer

Breast Cancer

Italy
Genesys
Novo Nordisk A/S

Completed

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Sepsis | Respiratory Failure | Renal Failure | Surgical Site Infection

United States
West Japan Thoracic Oncology Group

Completed

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Lung Cancer
Rambam Health Care Campus
Roche Pharma AG

Unknown

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Adenocarcinoma Clear Cell

Israel
Rennes University Hospital
Ministry of Health, France

Terminated

Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.

Metastatic Renal Cell Carcinoma

France
National Taiwan University Hospital

Unknown

Effects of Arsenic on Keratinocytes in a Skin Equivalent Model

Bowen Disease

Taiwan
Inje University

Unknown

Random Trial for Elderly Patients With NSCLC

Non-Small Cell Lung Cancer

Korea, Republic of
St. John Providence Health System
Eli Lilly and Company; Genentech, Inc.

Unknown

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

Non-Small Cell Lung Cancer

United States
National Taiwan University Hospital

Unknown

Mesothelin as a New Tumor Marker for Ovarian Cancer

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Methylation Status of CD44 Promoter Region in Primary Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis

Non-Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Completed

Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers

Locally Advanced and Recurrent/Metastatic Gastric Cancer
The Cooper Health System

Unknown

Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)

Untreated Advanced Non-Small Cell Lung Cancer

United States

Search clinical trials for: unresectable hepatocellular carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations